Note: Ingredients listed on restricted chemical lists
EC/CAS
57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
>=30-<50
General Information
Version
1.1
Revision date
2024-02-13
Product name
BUSCAP. COMP.NF,FICTA/ 30/10+500MG BLI C0
Product Synonyms
Viramune® oral suspension 50mg/5ml with active ingredient: Nevirapine Hemihydrate
1.2.1 Relevant identified uses
Pharmaceutical
1.2.2. Uses advised against
Safety Data Sheet only for the professional user
supplier name
Boehringer Ing. Pharma GmbH & Co. KG
Emergency telephone
+1 703-527-3887, +49800 1817059
Icons in SDS
Company Information
company name
Boehringer Ing. Pharma GmbH & Co. KG
e-mail address of the competent person responsible for the Safety Data Sheet
EHS-Services@Boehringer-Ingelheim.com
Section 2
SECTION 2: Hazards identification
OSHA Hazards GHS classification in accordance with the
2.2 Label elements
No hazard pictogram, no signal word, no hazard statement(s), no precautionary statement(s) re- quired
2.3 Other hazards
This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS) The pharmacological effect of the medicament has to be considered (see package leaflet).